The two tissue layers the report is describing

The report is describing damage to two layers that sit directly on top of each other at the ankle joint — think of it like paint peeling from a concrete step, where both the surface coating and the substrate beneath it are compromised.

The word 'osteochondral' breaks into two parts: osteo refers to bone, and chondral refers to cartilage. In this context, the talus is the rounded bone at the top of the ankle that acts as the joint's primary load-bearing dome — it absorbs impact on every step, stride, and landing. Covering its upper surface is a thin layer of articular cartilage, the smooth, slippery tissue that allows the joint to move without friction. Directly beneath that cartilage sits the subchondral bone, a dense layer that cushions and supports the cartilage above.

An osteochondral defect means something has gone wrong in one or both of these layers. The cartilage may be softened, cracked, or partially detached. The bone beneath it may show bruising, cracks, or fluid-filled cavities. The MRI report names both layers separately because damage to each carries different implications for how the joint behaves and, critically, for which treatment pathway is appropriate.

Why MRI was ordered and what it can see that other scans cannot

A plain X-ray is often the first scan a GP orders when ankle pain persists — and it has genuine uses: it can show bone alignment, obvious fractures, and marked joint-space narrowing. What it cannot show is cartilage, because cartilage contains no calcium and is effectively invisible to X-ray. Early changes in the subchondral bone — the bruising, microcracks, and fluid-filled cysts that may accompany an osteochondral injury — are equally beyond its reach.

CT scanning adds useful detail on bony structure and comes into its own later, when a surgeon needs to assess the precise geometry of a lesion before operating. For initial diagnosis, though, it shares the same limitation: purely cartilaginous lesions and lesions where no bone fragment has shifted position simply do not appear on CT.

MRI closes both gaps in a single examination. It simultaneously visualises the cartilage surface, the subchondral bone, and the fluid environment around the joint — detecting bone marrow oedema, cartilage thinning or fissuring, and fluid signals that can indicate an unstable fragment. That combination of soft-tissue and early bone sensitivity is precisely why MRI is the preferred modality for talar osteochondral defects, and why its findings carry considerably more diagnostic weight than an X-ray result for this particular injury.

The measurements and features that matter most in the report

Once the radiologist's report is in hand, five features tend to matter most to the clinician reviewing it — and understanding what each term signals can help make sense of a follow-up conversation.

1. Lesion size — this is the most clinically actionable number in the report. Research across studies of 105 and 168 ankle osteochondral lesions establishes a clear threshold: lesions with an average diameter below 15 mm (or below 150 mm² in cross-sectional area on MRI) had essentially no treatment failures when managed with marrow stimulation techniques such as microfracture. At or above that threshold, the same approach succeeded in only around 3% of cases — meaning size alone can redirect the entire surgical pathway towards more complex cartilage restoration. If the report states a lesion diameter or area, that number is worth noting before any specialist appointment.

2. Containment — whether intact cartilage surrounds the defect on all sides. A contained lesion (healthy cartilage forming a complete border) tends to respond better to less invasive approaches. An uncontained lesion, where the defect reaches the edge of the cartilage, generally represents a more complex repair problem.

3. Subchondral cysts — fluid-filled cavities beneath the defect. Their presence worsens prognosis and often means that bone grafting needs to accompany any cartilage repair, rather than cartilage work alone.

4. Fragment stability — when the report describes fluid signal between a bone fragment and the surrounding parent bone, this indicates the fragment may be loose or mobile. An unstable fragment changes the surgical decision significantly: fixation, removal, or more substantial reconstruction may be needed.

5. Bone marrow oedema — described as bright signal on STIR or T2-weighted sequences. Heavy or extensive oedema suggests the lesion is still active or evolving, which has implications for timing any intervention.

Grading labels (such as 'Grade 3' or 'Stage II') vary between radiologists and classification systems; the five features above are the practical currency clinicians use to plan treatment regardless of which label appears in the report.

How your symptoms fit — or don't — with the imaging

Symptoms and scan findings do not always move in lockstep — and for talar osteochondral defects, the gap between them can genuinely surprise people.

In the earlier stages, the dominant symptom is typically ankle pain during or after activity, sometimes accompanied by mild swelling that settles with rest. MRI at this point may reveal bone marrow oedema, early cartilage thinning, or a small contained defect — findings that can look more significant on paper than the patient's daily experience might suggest. That disconnect is not unusual; it reflects the sensitivity of MRI rather than an error in either the scan or the patient's perception.

When a lesion progresses to the point where a fragment becomes unstable or loose within the joint, the symptom pattern shifts. Mechanical symptoms — a catching or locking sensation, joint swelling that recurs without obvious cause, a feeling of something moving inside the ankle — tend to correspond on MRI to fragmentation, displaced bone, or a visible joint effusion.

It is also worth knowing that an osteochondral change picked up incidentally on a scan done for another reason, in an ankle that is genuinely pain-free and fully functional, does not automatically require treatment. Management decisions are never based on imaging alone.

Bringing the two pictures together — what the scan shows and what the patient is actually experiencing — is precisely the work of a specialist assessment, and forms the starting point for any treatment discussion.

Why cartilage cannot repair itself

The reason an osteochondral defect warrants attention — even when symptoms feel manageable — lies in a basic property of cartilage: it has no direct blood supply. Unlike bone, muscle, or tendon, articular cartilage relies entirely on synovial fluid circulated through the joint by movement to deliver oxygen and nutrients to its cells. That arrangement works well for an intact surface, but it means that once the cartilage is breached, no local vascular response can arrive to begin repair. The biological machinery that closes a skin wound or knits a fractured bone simply is not present.

The subchondral bone beneath the defect does have a blood supply and can respond to injury — but the tissue it produces is fibrocartilage rather than the original hyaline cartilage. Fibrocartilage is mechanically inferior and less durable under the repetitive loading of an ankle joint, which is why untreated lesions tend not to stabilise naturally over time.

This is not a reason for alarm, but it does explain why monitoring or some form of intervention is always appropriate. These lesions do not self-repair; waiting without a plan is rarely the right default.

What the MRI findings suggest for next steps

The MRI findings, read alongside clinical history and examination, map fairly directly onto a treatment pathway.

Lesions that are small, stable, and contained — with no cysts and within the size threshold discussed earlier — are reasonable candidates for conservative management, or for marrow stimulation (microfracture) if symptoms persist despite that. When a lesion is larger, cystic, or has already failed marrow stimulation, the clinical case shifts toward cartilage restoration procedures — OATS (mosaicplasty), AMIC, or autologous chondrocyte implantation — which rebuild a mechanically appropriate surface rather than relying on fibrocartilage fill. Where the MRI shows a loose or displaced fragment, arthroscopic removal or fixation is generally indicated regardless of lesion size, since a fragment moving within the joint is a mechanical problem that monitoring alone cannot resolve.

The imaging guides but does not determine the decision. A consultant will also weigh how long symptoms have been present, how limiting they are day to day, and what the patient's activity demands are before settling on a recommendation.

If an osteochondral defect appears on your MRI report, the right next step is a specialist assessment by a clinician who works regularly with ankle cartilage — not because the findings are automatically alarming, but because the options and their trade-offs need to be matched to your specific presentation. The London Cartilage Clinic on Harley Street offers dedicated cartilage assessment for exactly this type of diagnosis. You can arrange an appointment at londoncartilage.com.

1. [1] Osteochondritis dissecans. https://en.wikipedia.org/?curid=3762029 https://en.wikipedia.org/?curid=3762029